Strauch Ulrich, Bergmans Dennis C J J, Habers Joachim, Jansen Jochen, Winkens Bjorn, Veldman Dirk J, Roekaerts Paul M H J, Beckers Stefan K
Department of Intensive Care, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Emergency Medical Service district of Aachen, Aachen, Germany.
BMJ Open. 2017 Mar 10;7(3):e012861. doi: 10.1136/bmjopen-2016-012861.
It is widely accepted that transportation of critically ill patients is high risk. Unfortunately, however, there are currently no evidence-based criteria with which to determine the quality of various interhospital transport systems and their impact on the outcomes for patients. We aim to rectify this by assessing 2 scores which were developed in our hospital in a prospective, observational study. Primarily, we will be examining the Quality of interhospital critical care transportation in the Euregion Meuse-Rhine (QUIT EMR) score, which focuses on the quality of the transport system, and secondarily the SEMROS (Simplified EMR outcome score) which detects changes in the patient's clinical condition in the 24 hours following their transportation.
A web-based application will be used to document around 150 pretransport, intratransport and post-transport items of each patient case.To be included, patients must be at least 18-years of age and should have been supervised by a physician during an interhospital transport which was started in the study region.The quality of the QUIT EMR score will be assessed by comparing 3 predefined levels of transport facilities: the high, medium and low standards. Subsequently, SEMROS will be used to determine the effect of transport quality on the morbidity 24 hours after transportation.It is estimated that there will be roughly 3000 appropriate cases suitable for inclusion in this study per year. Cases shall be collected from 1 April 2015 until 31 December 2017.
This trial was approved by the Ethics committees of the university hospitals of Maastricht (Netherlands) and Aachen (Germany). The study results will be published in a peer reviewed journal. Results of this study will determine if a prospective randomised trial involving patients of various categories being randomly assigned to different levels of transportation system shall be conducted.
NTR4937.
重症患者的转运具有高风险，这一点已被广泛认可。然而，遗憾的是，目前尚无基于证据的标准来判定各种医院间转运系统的质量及其对患者预后的影响。我们旨在通过一项前瞻性观察性研究评估我院制定的两个评分来纠正这一情况。首先，我们将研究欧洲默兹 - 莱茵地区医院间重症监护转运质量（QUIT EMR）评分，该评分侧重于转运系统的质量；其次研究简化的欧洲默兹 - 莱茵地区预后评分（SEMROS），该评分用于检测患者在转运后24小时内临床状况的变化。
将使用一个基于网络的应用程序记录每个患者病例的约150项转运前、转运中和转运后的项目。纳入的患者必须年满18岁，且在研究区域内启动的医院间转运过程中应由医生进行监护。将通过比较3个预定义的转运设施水平（高、中、低标准）来评估QUIT EMR评分的质量。随后，使用SEMROS来确定转运质量对转运后24小时发病率的影响。估计每年约有3000例合适的病例可纳入本研究。病例将从2015年4月1日收集至2017年12月31日。
本试验已获得荷兰马斯特里赫特大学医院和德国亚琛大学医院伦理委员会的批准。研究结果将发表在同行评审期刊上。本研究结果将决定是否开展一项前瞻性随机试验，将各类患者随机分配到不同水平的转运系统。
NTR4937。
